Committees

Industry Committee

Charter

The Industry Committee strives to:

  • Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.

Projects & Objectives

The Committee

Headshot of Anthony Ting

Chair

Anthony Ting, PhD

Bone Therapeutics
United States

Members

Sasha Aleksic

FUJIFILM

USA

 

Julie Allickson

Mayo Clinic

USA

 

Vivek Bhatnagar

West Pharmaceuticals

USA

 

Caroline Blumer Toti

Miltenyi

Germany

 

Becky Cap

BioBridge Global

USA

 

Bryan Choi

SCRM

Korea

Dominic Clarke

Discovery Life Sciences

USA

 

David Exline

Gateway Analytical

USA

 

Mark Flower

Cellares

USA

 

Miguel Forte

Bone Therapeutics

Belgium

 

Jason C. Foster

Oribiotech

USA

 

Maya Fuerstenau-Sharp

Sartorius

USA

Clive Glover

Pall

USA

 

Audrey Greenberg

Centre for Breakthrough Medicines

USA

 

Nacim Haderbache

Cytiva

USA

 

Matt Hewitt

Charles River

USA

 

Robert Jones

Cryoport

UK

 

Sven Kili

Antion Biosciences

UK

 

Uma Lakshmipathy

Thermo Fisher

USA

 

Antonio Lee

Medi-post

Korea

Bruce Levine

University of Pennsylvania School of Medicine

USA

 

David Lewandowski 

Azenta 

USA

 

Aby Mathew

BioLife Solutions

USA

 

Michael May

CCRM

Canada

 

Bill Milligan

Aventa Cell

Canada/Taiwan

 

Michitaka Nakao

FIRM

JAPAN

 

Dennis Powers

G Con Manufacturing

USA

 

Patrick Rivers

Aquillo Captial

USA

 

Alberto Sangastino

Lonza

EU

 

Antonia Scatena

Gateway Analytical

USA

Kathie Schneider

Terumo BCT

USA

 

David Smith

Akron

USA

 

Nathan Smith

Cell Therapies PTY Ltd

AUS 

 

Jennifer Solomon

STEMCELL

Canada

Yoshie Tsurumaki

FIRM

JAPAN

Phil Vanek

Gamma Bio

USA

 

Roman Vincent

MaxCyte 

USA

 

Kim Watanabe 

Patheon 

USA

 

Betty Woo

Thermo Fisher

USA

 

Sanjin Zvonic

Dark Horse Consulting

USA

View All Committees